FDA Clearance Tracker · K243236
WHOOP ECG (electrocardiogram) Feature (1.0)
Last checked: Nov 19, 2026Latest source record: Apr 4, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Apr 4, 2025
Substantially Equivalent
Time to decision
176 days
Received Oct 10, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K243236
- Device name
- WHOOP ECG (electrocardiogram) Feature (1.0)
- Applicant
- Whoop., Inc.
- Applicant location
- Boston, MA
- Received
- Oct 10, 2024
- Decided
- Apr 4, 2025
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 870.2345
- Specialty
- CardiologyElectrophysiology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code QDA. The earliest in FDA's data is DEN180044, decided Sep 11, 2018.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K243236
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Whoop., Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.